Cargando…

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xindi, Trendowski, Matthew R., Wilkinson, Emma, Shahbazi, Mohammad, Dinh, Paul C., Shuey, Megan M., Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Fung, Chunkit, Kollmannsberger, Christian, Huddart, Robert, Martin, Neil E., Sanchez, Victoria A., Frisina, Robert D., Einhorn, Lawrence H., Cox, Nancy J., Travis, Lois B., Dolan, M. Eileen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302309/
https://www.ncbi.nlm.nih.gov/pubmed/35322580
http://dx.doi.org/10.1002/cam4.4644
_version_ 1784751608745164800
author Zhang, Xindi
Trendowski, Matthew R.
Wilkinson, Emma
Shahbazi, Mohammad
Dinh, Paul C.
Shuey, Megan M.
Feldman, Darren R.
Hamilton, Robert J.
Vaughn, David J.
Fung, Chunkit
Kollmannsberger, Christian
Huddart, Robert
Martin, Neil E.
Sanchez, Victoria A.
Frisina, Robert D.
Einhorn, Lawrence H.
Cox, Nancy J.
Travis, Lois B.
Dolan, M. Eileen
author_facet Zhang, Xindi
Trendowski, Matthew R.
Wilkinson, Emma
Shahbazi, Mohammad
Dinh, Paul C.
Shuey, Megan M.
Feldman, Darren R.
Hamilton, Robert J.
Vaughn, David J.
Fung, Chunkit
Kollmannsberger, Christian
Huddart, Robert
Martin, Neil E.
Sanchez, Victoria A.
Frisina, Robert D.
Einhorn, Lawrence H.
Cox, Nancy J.
Travis, Lois B.
Dolan, M. Eileen
author_sort Zhang, Xindi
collection PubMed
description PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the confounding effect of cranial radiotherapy. METHODS: Utilizing linear and logistic regression analyses on 1680 well‐characterized cisplatin‐treated testicular cancer survivors, we analyzed associations of hearing loss, tinnitus, and peripheral neuropathy with nongenetic comorbidities. Genome‐wide association studies and gene‐based analyses were performed on each phenotype. RESULTS: Hearing loss, tinnitus, and peripheral neuropathy, accounting for age and cisplatin dose, were interdependent. Survivors with these neurotoxicities experienced more hypertension and poorer self‐reported health. In addition, hearing loss was positively associated with BMIs at clinical evaluation and nonwork‐related noise exposure (>5 h/week). Tinnitus was positively associated with tobacco use, hypercholesterolemia, and noise exposure. We observed positive associations between peripheral neuropathy and persistent vertigo, tobacco use, and excess alcohol consumption. Hearing loss and TXNRD1, which plays a key role in redox regulation, showed borderline significance (p = 4.2 × 10(−6)) in gene‐based analysis. rs62283056 in WFS1 previously found to be significantly associated with hearing loss (n = 511), was marginally significant in an independent replication cohort (p = 0.06; n = 606). Gene‐based analyses identified significant associations between tinnitus and WNT8A (p = 2.5 × 10(−6)), encoding a signaling protein important in germ cell tumors. CONCLUSIONS: Genetics variants in TXNRD1 and WNT8A are notable risk factors for hearing loss and tinnitus, respectively. Future studies should investigate these genes and if replicated, identify their potential impact on preventive strategies.
format Online
Article
Text
id pubmed-9302309
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93023092022-07-22 Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy Zhang, Xindi Trendowski, Matthew R. Wilkinson, Emma Shahbazi, Mohammad Dinh, Paul C. Shuey, Megan M. Feldman, Darren R. Hamilton, Robert J. Vaughn, David J. Fung, Chunkit Kollmannsberger, Christian Huddart, Robert Martin, Neil E. Sanchez, Victoria A. Frisina, Robert D. Einhorn, Lawrence H. Cox, Nancy J. Travis, Lois B. Dolan, M. Eileen Cancer Med RESEARCH ARTICLES PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the confounding effect of cranial radiotherapy. METHODS: Utilizing linear and logistic regression analyses on 1680 well‐characterized cisplatin‐treated testicular cancer survivors, we analyzed associations of hearing loss, tinnitus, and peripheral neuropathy with nongenetic comorbidities. Genome‐wide association studies and gene‐based analyses were performed on each phenotype. RESULTS: Hearing loss, tinnitus, and peripheral neuropathy, accounting for age and cisplatin dose, were interdependent. Survivors with these neurotoxicities experienced more hypertension and poorer self‐reported health. In addition, hearing loss was positively associated with BMIs at clinical evaluation and nonwork‐related noise exposure (>5 h/week). Tinnitus was positively associated with tobacco use, hypercholesterolemia, and noise exposure. We observed positive associations between peripheral neuropathy and persistent vertigo, tobacco use, and excess alcohol consumption. Hearing loss and TXNRD1, which plays a key role in redox regulation, showed borderline significance (p = 4.2 × 10(−6)) in gene‐based analysis. rs62283056 in WFS1 previously found to be significantly associated with hearing loss (n = 511), was marginally significant in an independent replication cohort (p = 0.06; n = 606). Gene‐based analyses identified significant associations between tinnitus and WNT8A (p = 2.5 × 10(−6)), encoding a signaling protein important in germ cell tumors. CONCLUSIONS: Genetics variants in TXNRD1 and WNT8A are notable risk factors for hearing loss and tinnitus, respectively. Future studies should investigate these genes and if replicated, identify their potential impact on preventive strategies. John Wiley and Sons Inc. 2022-03-23 /pmc/articles/PMC9302309/ /pubmed/35322580 http://dx.doi.org/10.1002/cam4.4644 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Zhang, Xindi
Trendowski, Matthew R.
Wilkinson, Emma
Shahbazi, Mohammad
Dinh, Paul C.
Shuey, Megan M.
Feldman, Darren R.
Hamilton, Robert J.
Vaughn, David J.
Fung, Chunkit
Kollmannsberger, Christian
Huddart, Robert
Martin, Neil E.
Sanchez, Victoria A.
Frisina, Robert D.
Einhorn, Lawrence H.
Cox, Nancy J.
Travis, Lois B.
Dolan, M. Eileen
Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title_full Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title_fullStr Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title_full_unstemmed Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title_short Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
title_sort pharmacogenomics of cisplatin‐induced neurotoxicities: hearing loss, tinnitus, and peripheral sensory neuropathy
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302309/
https://www.ncbi.nlm.nih.gov/pubmed/35322580
http://dx.doi.org/10.1002/cam4.4644
work_keys_str_mv AT zhangxindi pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT trendowskimatthewr pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT wilkinsonemma pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT shahbazimohammad pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT dinhpaulc pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT shueymeganm pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT feldmandarrenr pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT hamiltonrobertj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT vaughndavidj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT fungchunkit pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT kollmannsbergerchristian pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT huddartrobert pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT martinneile pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT sanchezvictoriaa pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT frisinarobertd pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT einhornlawrenceh pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT coxnancyj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT travisloisb pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy
AT dolanmeileen pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy